FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4292648558> ?p ?o ?g. }

• W4292648558 abstract "Knee arthroscopy (KA) is a routine orthopedic procedure recommended to repair cruciate ligaments and meniscus injuries and, in suitable cases, to assist the diagnosis of persistent knee pain. There is a small risk of thromboembolic events associated with KA. This systematic review aims to assess if pharmacological or non-pharmacological interventions may reduce this risk. This is an update of an earlier Cochrane Review.To evaluate the efficacy and safety of interventions - whether mechanical, pharmacological, or a combination of both - for thromboprophylaxis in adults undergoing KA.We used standard, extensive Cochrane search methods. The latest search date was 1 June 2021.We included randomized controlled trials (RCTs) and controlled clinical trials (CCTs), blinded or unblinded, of all types of interventions used to prevent deep vein thrombosis (DVT) in men and women aged 18 years and older undergoing KA.We used standard Cochrane methods. Our primary outcomes were pulmonary embolism (PE), symptomatic DVT, asymptomatic DVT, and all-cause mortality. Our secondary outcomes were adverse effects, major bleeding, and minor bleeding. We used GRADE criteria to assess the certainty of the evidence.We did not identify any new studies for this update. This review includes eight studies involving 3818 adults with no history of thromboembolic disease. Five studies compared daily subcutaneous low-molecular-weight heparin (LMWH) versus no prophylaxis; one study compared oral rivaroxaban 10 mg versus placebo; one study compared daily subcutaneous LMWH versus graduated compression stockings; and one study compared aspirin versus no prophylaxis. The incidence of PE in all studies combined was low, with seven cases in 3818 participants. There were no deaths in any of the intervention or control groups. Low-molecular-weight heparin versus no prophylaxis When compared with no prophylaxis, LMWH probably results in little to no difference in the incidence of PE in people undergoing KA (risk ratio [RR] 1.81, 95% confidence interval [CI] 0.49 to 6.65; 3 studies, 1820 participants; moderate-certainty evidence). LMWH may make little or no difference to the incidence of symptomatic DVT (RR 0.61, 95% CI 0.18 to 2.03; 4 studies, 1848 participants; low-certainty evidence). It is uncertain whether LMWH reduces the risk of asymptomatic DVT (RR 0.14, 95% CI 0.03 to 0.61; 2 studies, 369 participants; very low-certainty evidence). LMWH probably makes little or no difference to the risk of all adverse effects combined (RR 1.85, 95% CI 0.95 to 3.59; 5 studies, 1978 participants; moderate-certainty evidence), major bleeding (RR 0.98, 95% CI 0.06 to 15.72; 1451 participants; moderate-certainty evidence), or minor bleeding (RR 1.79, 95% CI 0.84 to 3.84; 5 studies, 1978 participants; moderate-certainty evidence). Rivaroxaban versus placebo One study with 234 participants compared oral rivaroxaban 10 mg versus placebo. There were no cases of PE reported. Rivaroxaban probably led to little or no difference in symptomatic DVT (RR 0.16, 95% CI 0.02 to 1.29; moderate-certainty evidence). It is uncertain whether rivaroxaban reduces the risk of asymptomatic DVT because the certainty of the evidence is very low (RR 0.95, 95% CI 0.06 to 15.01). The study only reported bleeding adverse effects. No major bleeds occurred in either group, and rivaroxaban probably made little or no difference to minor bleeding (RR 0.63, 95% CI 0.18 to 2.19; moderate-certainty evidence). Aspirin versus no prophylaxis One study compared aspirin with no prophylaxis. There were no PE, DVT or asymptomatic events detected in either group. The study authors reported adverse effects including pain and swelling, but without clarifying which groups these occurred in. There were no bleeds reported. Low-molecular-weight heparin versus compression stockings One study with 1317 participants compared LMWH versus compression stockings. LMWH may lead to little or no difference in the risk of PE compared to compression stockings (RR 1.00, 95% CI 0.14 to 7.05; low-certainty evidence), but it may reduce the risk of symptomatic DVT (RR 0.17, 95% CI 0.04 to 0.75; low-certainty evidence). It is uncertain whether LMWH has any effect on asymptomatic DVT (RR 0.47, 95% CI 0.21 to 1.09; very low-certainty evidence). The results suggest LMWH probably leads to little or no difference in major bleeding (RR 3.01, 95% CI 0.61 to 14.88; moderate-certainty evidence), or minor bleeding (RR 1.16, 95% CI 0.64 to 2.08; moderate-certainty evidence). We downgraded the certainty of the evidence for imprecision due to overall small event numbers, for risk of bias due to concerns about lack of blinding, and for indirectness due to uncertainty about the direct clinical relevance of asymptomatic DVT detection.There is a small risk that healthy adults undergoing KA will develop venous thromboembolism (PE or DVT). We found moderate- to low-certainty evidence of little or no benefit from LMWH, or rivaroxaban in reducing this small risk of PE or symptomatic DVT. The studies provided very low-certainty evidence that LMWH may reduce the risk of asymptomatic DVT compared to no prophylaxis, but it is uncertain how this directly relates to incidence of DVT or PE in healthy people undergoing KA. There is probably little or no difference in adverse effects (including major and minor bleeding), but data relating to these outcomes were limited by low numbers of events in the studies reporting these outcomes." @default.
• W4292648558 created "2022-08-22" @default.
• W4292648558 creator A5018783269 @default.
• W4292648558 creator A5031358178 @default.
• W4292648558 creator A5043697768 @default.
• W4292648558 creator A5064382771 @default.
• W4292648558 date "2022-08-22" @default.
• W4292648558 modified "2023-09-25" @default.
• W4292648558 title "Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy" @default.
• W4292648558 cites W113936436 @default.
• W4292648558 cites W1502106284 @default.
• W4292648558 cites W1569766984 @default.
• W4292648558 cites W1924177165 @default.
• W4292648558 cites W1978696511 @default.
• W4292648558 cites W1980261048 @default.
• W4292648558 cites W2024426842 @default.
• W4292648558 cites W2081385976 @default.
• W4292648558 cites W2110992040 @default.
• W4292648558 cites W2125435699 @default.
• W4292648558 cites W2150611687 @default.
• W4292648558 cites W2160022765 @default.
• W4292648558 cites W2161744108 @default.
• W4292648558 cites W2163834772 @default.
• W4292648558 cites W2165010366 @default.
• W4292648558 cites W2177961447 @default.
• W4292648558 cites W2337536182 @default.
• W4292648558 cites W2337952894 @default.
• W4292648558 cites W2557720224 @default.
• W4292648558 cites W2587933714 @default.
• W4292648558 cites W2808983908 @default.
• W4292648558 cites W29165754 @default.
• W4292648558 cites W3016782834 @default.
• W4292648558 cites W4210289314 @default.
• W4292648558 cites W4240291226 @default.
• W4292648558 cites W4246201333 @default.
• W4292648558 cites W4360754839 @default.
• W4292648558 doi "https://doi.org/10.1002/14651858.cd005259.pub5" @default.
• W4292648558 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35993965" @default.
• W4292648558 hasPublicationYear "2022" @default.
• W4292648558 type Work @default.
• W4292648558 citedByCount "2" @default.
• W4292648558 countsByYear W42926485582020 @default.
• W4292648558 countsByYear W42926485582022 @default.
• W4292648558 crossrefType "journal-article" @default.
• W4292648558 hasAuthorship W4292648558A5018783269 @default.
• W4292648558 hasAuthorship W4292648558A5031358178 @default.
• W4292648558 hasAuthorship W4292648558A5043697768 @default.
• W4292648558 hasAuthorship W4292648558A5064382771 @default.
• W4292648558 hasConcept C126322002 @default.
• W4292648558 hasConcept C141071460 @default.
• W4292648558 hasConcept C142724271 @default.
• W4292648558 hasConcept C168563851 @default.
• W4292648558 hasConcept C1862650 @default.
• W4292648558 hasConcept C197934379 @default.
• W4292648558 hasConcept C204787440 @default.
• W4292648558 hasConcept C27081682 @default.
• W4292648558 hasConcept C2776265017 @default.
• W4292648558 hasConcept C2776301958 @default.
• W4292648558 hasConcept C2777628954 @default.
• W4292648558 hasConcept C2778661090 @default.
• W4292648558 hasConcept C2778959117 @default.
• W4292648558 hasConcept C2779161974 @default.
• W4292648558 hasConcept C2780011451 @default.
• W4292648558 hasConcept C2780868729 @default.
• W4292648558 hasConcept C71924100 @default.
• W4292648558 hasConceptScore W4292648558C126322002 @default.
• W4292648558 hasConceptScore W4292648558C141071460 @default.
• W4292648558 hasConceptScore W4292648558C142724271 @default.
• W4292648558 hasConceptScore W4292648558C168563851 @default.
• W4292648558 hasConceptScore W4292648558C1862650 @default.
• W4292648558 hasConceptScore W4292648558C197934379 @default.
• W4292648558 hasConceptScore W4292648558C204787440 @default.
• W4292648558 hasConceptScore W4292648558C27081682 @default.
• W4292648558 hasConceptScore W4292648558C2776265017 @default.
• W4292648558 hasConceptScore W4292648558C2776301958 @default.
• W4292648558 hasConceptScore W4292648558C2777628954 @default.
• W4292648558 hasConceptScore W4292648558C2778661090 @default.
• W4292648558 hasConceptScore W4292648558C2778959117 @default.
• W4292648558 hasConceptScore W4292648558C2779161974 @default.
• W4292648558 hasConceptScore W4292648558C2780011451 @default.
• W4292648558 hasConceptScore W4292648558C2780868729 @default.
• W4292648558 hasConceptScore W4292648558C71924100 @default.
• W4292648558 hasIssue "8" @default.
• W4292648558 hasLocation W42926485581 @default.
• W4292648558 hasLocation W42926485582 @default.
• W4292648558 hasOpenAccess W4292648558 @default.
• W4292648558 hasPrimaryLocation W42926485581 @default.
• W4292648558 hasRelatedWork W1980752621 @default.
• W4292648558 hasRelatedWork W2031546188 @default.
• W4292648558 hasRelatedWork W2171652010 @default.
• W4292648558 hasRelatedWork W2355020846 @default.
• W4292648558 hasRelatedWork W2387624618 @default.
• W4292648558 hasRelatedWork W2410487325 @default.
• W4292648558 hasRelatedWork W2790885812 @default.
• W4292648558 hasRelatedWork W2981730791 @default.
• W4292648558 hasRelatedWork W3027698964 @default.
• W4292648558 hasRelatedWork W3111527613 @default.
• W4292648558 hasVolume "2022" @default.
• W4292648558 isParatext "false" @default.
• W4292648558 isRetracted "false" @default.

• next